A BILL 
To direct the Secretary of Health and Human Services to 
submit to Congress a weekly report on COVID–19 vac-
cine distribution, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Vaccine Fairness Act 
4
of 2020’’. 
5
SEC. 2. COVID–19 VACCINE DISTRIBUTION REPORT. 
6
(a) IN GENERAL.—Not later than 7 days after the 
7
date on which the Federal Government begins distributing 
8
COVID–19 vaccines for administration to the public, and 
9
every 7 days thereafter, the Secretary of Health and 
10
00:37 Oct 30, 2020
H8555
2 
•HR 8555 IH
Human Services (in this section referred to as the ‘‘Sec-
1
retary’’), in consultation with the Secretary of Defense, 
2
shall submit to Congress a report on the effectiveness of 
3
efforts relating to the distribution of COVID–19 vaccines 
4
to the public. 
5
(b) CONTENTS OF REPORT.—Each report submitted 
6
under subsection (a) shall include, with respect to the 7- 
7
day period preceding the date on which such report is sub-
8
mitted, the following: 
9
(1) The number of doses of COVID–19 vaccines 
10
distributed for administration to the public. 
11
(2) A description of any substantial purchase of 
12
COVID–19 vaccines by a Federal Government agen-
13
cy or private organization. 
14
(3) The number of doses of COVID–19 vaccines 
15
that were distributed to State or local health depart-
16
ments. 
17
(4) A description of the progress made in dis-
18
tributing COVID–19 vaccines to the following: 
19
(A) High-risk and other priority groups, 
20
including— 
21
(i) racial and ethnic minorities; 
22
(ii) individuals who are pregnant or 
23
breastfeeding; 
24
(iii) individuals with disabilities; 
25
00:37 Oct 30, 2020
H8555
3 
•HR 8555 IH
(iv) homeless individuals; 
1
(v) newly resettled refugees; and 
2
(vi) individuals in rural communities. 
3
(B) High-risk facilities, including— 
4
(i) long-term care facilities; 
5
(ii) group homes; and 
6
(iii) jails and prisons. 
7
(5) A description of any deviations from Fed-
8
eral distribution plans, including issues relating to 
9
the following: 
10
(A) Sites administering large numbers of 
11
COVID–19 vaccines, such as pharmacy chain 
12
stores, schools, and primary health care pro-
13
viders. 
14
(B) Tracking procedures for COVID–19 
15
vaccines, particularly in areas of greatest need. 
16
(C) Outreach to health care providers and 
17
the public about the availability, benefits, safe-
18
ty, contraindications, and costs of receiving 
19
COVID–19 vaccines. 
20
(D) Outreach to health care providers re-
21
garding the responsibilities of such providers to 
22
track vaccine administration and monitor ad-
23
verse events. 
24
00:37 Oct 30, 2020
H8555
4 
•HR 8555 IH
(E) Uniform record keeping relating to the 
1
administration of COVID–19 vaccines (includ-
2
ing Federal support for State and local immuni-
3
zation information systems). 
4
(F) Overuse or gaps in treatment. 
5
(c) BRIEFINGS.—On each date on which the Sec-
6
retary submits to Congress a report under subsection (a), 
7
the Secretary shall be available to brief Congress on the 
8
contents of such report. 
9
(d) TERMINATION.—This section shall cease to have 
10
effect on the date that is 18 months after the date on 
11
which the initial report is submitted to Congress under 
12
subsection (a). 
13
(e) STATE DEFINED.—In this section, the term 
14
‘‘State’’ means each of the several States, the District of 
15
Columbia, each commonwealth, territory, or possession of 
16
the United States, and each federally recognized Indian 
17
Tribe. 
18
Æ 
00:37 Oct 30, 2020
H8555
